Key result
Intravenous rtPA for acute ischemic stroke precedes unusually early STEMI within 40 minutes.
Why the study?
Acute STEMI is a rare complication of acute ischemic stroke during thrombolytic therapy, prompting this report of STEMI occurring 40 minutes after thrombolysis to discuss possible mechanisms and therapeutic approaches.
Case Report (n=1)
STEMI can occur as a rare, early complication of thrombolytic therapy for acute ischemic stroke, and may be signaled by a third-degree atrioventricular block.
No takes yet. Share an insight, caveat, or question.
STEMI may complicate thrombolysis for AIS; this Level 5 case leaves open questions on incidence, mechanisms, and management.
Manea et al. (2018) conducted a case report in Acute ischemic stroke and ST-segment elevation myocardial infarction (n=1). Intravenous recombinant tissue plasminogen activator (i.v. rtPA) was evaluated on Occurrence of STEMI. An 87-year-old woman developed an unusually early ST-segment elevation myocardial infarction just 40 minutes after receiving intravenous rtPA for acute ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: